Schafer Cullen Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-368,556
Closed -$18.4M 222
2019
Q4
$18.4M Sell
368,556
-317,717
-46% -$15.8M 0.22% 76
2019
Q3
$30.6M Sell
686,273
-362,951
-35% -$16.2M 0.37% 69
2019
Q2
$42.2M Buy
1,049,224
+10,376
+1% +$417K 0.5% 63
2019
Q1
$42M Sell
1,038,848
-243,350
-19% -$9.84M 0.62% 57
2018
Q4
$48.7M Sell
1,282,198
-268,163
-17% -$10.2M 0.75% 50
2018
Q3
$61.3M Sell
1,550,361
-2,684,198
-63% -$106M 0.8% 55
2018
Q2
$149M Sell
4,234,559
-228,486
-5% -$8.02M 1.92% 12
2018
Q1
$156M Buy
4,463,045
+83,770
+2% +$2.93M 1.88% 10
2017
Q4
$152M Sell
4,379,275
-50,872
-1% -$1.77M 1.77% 14
2017
Q3
$150M Buy
4,430,147
+217,883
+5% +$7.38M 1.81% 15
2017
Q2
$144M Buy
4,212,264
+10,002
+0.2% +$341K 1.79% 14
2017
Q1
$131M Buy
4,202,262
+554,852
+15% +$17.3M 1.68% 22
2016
Q4
$99.6M Sell
3,647,410
-587,442
-14% -$16M 1.35% 33
2016
Q3
$139M Sell
4,234,852
-84,133
-2% -$2.76M 1.67% 21
2016
Q2
$130M Sell
4,318,985
-34,559
-0.8% -$1.04M 1.58% 26
2016
Q1
$123M Buy
4,353,544
+120,125
+3% +$3.38M 1.5% 28
2015
Q4
$144M Sell
4,233,419
-78,658
-2% -$2.67M 1.71% 20
2015
Q3
$137M Buy
4,312,077
+208,229
+5% +$6.63M 1.57% 24
2015
Q2
$131M Sell
4,103,848
-95,656
-2% -$3.05M 1.35% 31
2015
Q1
$144M Buy
4,199,504
+800,920
+24% +$27.4M 1.42% 30
2014
Q4
$120M Sell
3,398,584
-1,195,342
-26% -$42.1M 1.51% 29
2014
Q3
$164M Sell
4,593,926
-193,350
-4% -$6.91M 1.57% 24
2014
Q2
$178M Sell
4,787,276
-2,784,350
-37% -$103M 1.64% 21
2014
Q1
$246M Sell
7,571,626
-51,094
-0.7% -$1.66M 2.38% 3
2013
Q4
$226M Buy
7,622,720
+28,410
+0.4% +$843K 2.24% 6
2013
Q3
$197M Buy
7,594,310
+166,478
+2% +$4.32M 2.17% 9
2013
Q2
$176M Buy
+7,427,832
New +$176M 2.1% 13